BRAF mutation confirmed as a strong target for cancer drugs
Thursday, June 10, 2010 - 08:02
in Health & Medicine
(PhysOrg.com) -- Research has added to the evidence that a genetic mutation found in over 60 per cent of malignant melanomas is an important target for drugs to treat the disease.